• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety and Efficacy of Secukinumab in a Child with CARD14-Associated Papulosquamous Eruption: A Case Report and Review of Literature.

作者信息

Chiramel Minu J, Sathishkumar Dharshini, Jayakrishna A

机构信息

Department of Dermatology, Venereology and Leprosy, Christian Medical College, Vellore, Tamil Nadu, India.

出版信息

Indian Dermatol Online J. 2024 Sep 12;16(3):462-465. doi: 10.4103/idoj.idoj_180_24. eCollection 2025 May-Jun.

DOI:10.4103/idoj.idoj_180_24
PMID:40395577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12088470/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2871/12088470/8ae3d018d367/IDOJ-16-462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2871/12088470/826472864594/IDOJ-16-462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2871/12088470/8ae3d018d367/IDOJ-16-462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2871/12088470/826472864594/IDOJ-16-462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2871/12088470/8ae3d018d367/IDOJ-16-462-g002.jpg

相似文献

1
Safety and Efficacy of Secukinumab in a Child with CARD14-Associated Papulosquamous Eruption: A Case Report and Review of Literature.司库奇尤单抗治疗CARD14相关丘疹鳞屑性皮疹患儿的安全性和有效性：一例病例报告及文献综述
Indian Dermatol Online J. 2024 Sep 12;16(3):462-465. doi: 10.4103/idoj.idoj_180_24. eCollection 2025 May-Jun.
2
Missense Variant Underlying -Associated Papulosquamous Eruption with Beneficial Response to Secukinumab.与对司库奇尤单抗有良好反应相关的丘疹鳞屑性皮疹的潜在错义变异。
JID Innov. 2022 Dec 11;3(2):100174. doi: 10.1016/j.xjidi.2022.100174. eCollection 2023 Mar.
3
Histopathologic findings characteristic of CARD14-associated papulosquamous eruption.具有 CARD14 相关丘疹鳞屑性疹的组织病理学特征。
J Cutan Pathol. 2020 May;47(5):425-430. doi: 10.1111/cup.13633. Epub 2019 Dec 26.
4
Similar Molecular Features in Two Cases of CARD14-Associated Papulosquamous Eruption.
Australas J Dermatol. 2025 May;66(3):e171-e175. doi: 10.1111/ajd.14455. Epub 2025 Mar 14.
5
CARD14-associated papulosquamous eruption (CAPE) in a toddler responding to treatment with acitretin.卡德 14 相关的丘疹鳞屑性发疹（CAPE）在幼儿中对阿维 A 治疗有反应。
Pediatr Dermatol. 2021 Jul;38(4):970-972. doi: 10.1111/pde.14638. Epub 2021 Jun 2.
6
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.CARD14 相关的丘疹鳞屑性发疹：包括银屑病和毛发红糠疹特征的谱。
J Am Acad Dermatol. 2018 Sep;79(3):487-494. doi: 10.1016/j.jaad.2018.02.034. Epub 2018 Mar 1.
7
CARD14-associated papulosquamous eruption flare-up after SARS-CoV-2 infection in a child: secukinumab a safe and effective treatment.一名儿童感染新型冠状病毒后伴发与CARD14相关的丘疹鳞屑性皮疹发作：司库奇尤单抗是一种安全有效的治疗方法。
Int J Dermatol. 2023 Oct;62(10):1304-1306. doi: 10.1111/ijd.16790. Epub 2023 Jul 8.
8
CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.儿童患者的 CARD14 相关丘疹鳞屑性发疹（CAPE）：三例额外病例及文献复习。
Pediatr Dermatol. 2021 Sep;38(5):1237-1242. doi: 10.1111/pde.14779. Epub 2021 Aug 26.
9
Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel mutation.病例报告：一名患有严重炎症性皮肤病且有新突变的儿科患者使用生物制剂治疗成功。
Front Med (Lausanne). 2024 Feb 5;11:1360248. doi: 10.3389/fmed.2024.1360248. eCollection 2024.
10
A novel mutation in a CARD14-associated papulosquamous eruption.一种与 CARD14 相关的丘疹鳞屑性发疹相关的新型突变。
Pediatr Dermatol. 2023 Jul-Aug;40(4):706-709. doi: 10.1111/pde.15254. Epub 2023 Feb 1.

本文引用的文献

1
CARD14-associated papulosquamous eruption flare-up after SARS-CoV-2 infection in a child: secukinumab a safe and effective treatment.一名儿童感染新型冠状病毒后伴发与CARD14相关的丘疹鳞屑性皮疹发作：司库奇尤单抗是一种安全有效的治疗方法。
Int J Dermatol. 2023 Oct;62(10):1304-1306. doi: 10.1111/ijd.16790. Epub 2023 Jul 8.
2
A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.一名患有CARD14相关丘疹鳞屑性皮疹（CAPE）的儿童用优特克单抗成功治疗。
Pediatr Dermatol. 2023 Nov-Dec;40(6):1104-1106. doi: 10.1111/pde.15336. Epub 2023 May 23.
3
Missense Variant Underlying -Associated Papulosquamous Eruption with Beneficial Response to Secukinumab.
与对司库奇尤单抗有良好反应相关的丘疹鳞屑性皮疹的潜在错义变异。
JID Innov. 2022 Dec 11;3(2):100174. doi: 10.1016/j.xjidi.2022.100174. eCollection 2023 Mar.
4
Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child.乌司奴单抗治疗巴西儿童 CARD14 相关丘疹鳞屑疹有效。
Dermatol Ther. 2022 Dec;35(12):e15939. doi: 10.1111/dth.15939. Epub 2022 Oct 26.
5
Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.CARD14 相关丘疹鳞屑性疹的临床应答与抗白细胞介素-17A 抗体。
Br J Dermatol. 2022 Sep;187(3):419-422. doi: 10.1111/bjd.21229. Epub 2022 May 20.
6
CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.儿童患者的 CARD14 相关丘疹鳞屑性发疹（CAPE）：三例额外病例及文献复习。
Pediatr Dermatol. 2021 Sep;38(5):1237-1242. doi: 10.1111/pde.14779. Epub 2021 Aug 26.
7
Clinical response to ustekinumab in CARD14-associated papulosquamous eruption (CAPE) with a new missense mutation in CARD14: a case report and systematic review.乌司奴单抗治疗伴有CARD14新错义突变的CARD14相关丘疹鳞屑性皮疹（CAPE）的临床反应：一例报告及系统评价
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e728-e730. doi: 10.1111/jdv.16548. Epub 2020 May 27.
8
Two cases of CARD14-associated papulosquamous eruption from India.来自印度的两例与CARD14相关的丘疹鳞屑性皮疹病例。
Pediatr Dermatol. 2020 Jul;37(4):692-694. doi: 10.1111/pde.14172. Epub 2020 Apr 23.
9
Clinical and Genetic Heterogeneity of Mutations in Psoriatic Skin Disease.在银屑病患者中突变的临床与遗传异质性。
Front Immunol. 2018 Oct 16;9:2239. doi: 10.3389/fimmu.2018.02239. eCollection 2018.
10
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.CARD14 相关的丘疹鳞屑性发疹：包括银屑病和毛发红糠疹特征的谱。
J Am Acad Dermatol. 2018 Sep;79(3):487-494. doi: 10.1016/j.jaad.2018.02.034. Epub 2018 Mar 1.